These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24376574)

  • 21. Dopamine-dependent high-frequency oscillatory activity in thalamus and subthalamic nucleus of patients with Parkinson's disease.
    Kane A; Hutchison WD; Hodaie M; Lozano AM; Dostrovsky JO
    Neuroreport; 2009 Nov; 20(17):1549-53. PubMed ID: 19829159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease.
    Wang DD; de Hemptinne C; Miocinovic S; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    J Neurosci; 2018 May; 38(19):4556-4568. PubMed ID: 29661966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary roles of different oscillatory activities in the subthalamic nucleus in coding motor effort in Parkinsonism.
    Tan H; Pogosyan A; Anzak A; Ashkan K; Bogdanovic M; Green AL; Aziz T; Foltynie T; Limousin P; Zrinzo L; Brown P
    Exp Neurol; 2013 Oct; 248():187-95. PubMed ID: 23778147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiological recordings from electrodes implanted in the basal ganglia for deep brain stimulation in Parkinson's disease. the relevance of fast subthalamic rhythms.
    Foffani G; Ardolino G; Rampini P; Tamma F; Caputo E; Egidi M; Cerutti S; Barbieri S; Priori A
    Acta Neurochir Suppl; 2005; 93():97-9. PubMed ID: 15986736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of inter-electrode distance on subthalamic nucleus local field potential recordings in Parkinson's disease.
    Averna A; Marceglia S; Arlotti M; Locatelli M; Rampini P; Priori A; Bocci T
    Clin Neurophysiol; 2022 Jan; 133():29-38. PubMed ID: 34794045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Movement-related modulation of neural activity in human basal ganglia and its L-DOPA dependency: recordings from deep brain stimulation electrodes in patients with Parkinson's disease.
    Priori A; Foffani G; Pesenti A; Bianchi A; Chiesa V; Baselli G; Caputo E; Tamma F; Rampini P; Egidi M; Locatelli M; Barbieri S; Scarlato G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S101-2. PubMed ID: 12548363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic therapy promotes lateralized motor activity in the subthalamic area in Parkinson's disease.
    Androulidakis AG; Kühn AA; Chen CC; Blomstedt P; Kempf F; Kupsch A; Schneider GH; Doyle L; Dowsey-Limousin P; Hariz MI; Brown P
    Brain; 2007 Feb; 130(Pt 2):457-68. PubMed ID: 17213215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waveform changes with the evolution of beta bursts in the human subthalamic nucleus.
    Yeh CH; Al-Fatly B; Kühn AA; Meidahl AC; Tinkhauser G; Tan H; Brown P
    Clin Neurophysiol; 2020 Sep; 131(9):2086-2099. PubMed ID: 32682236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propagation of beta/gamma rhythms in the cortico-basal ganglia circuits of the parkinsonian rat.
    West TO; Berthouze L; Halliday DM; Litvak V; Sharott A; Magill PJ; Farmer SF
    J Neurophysiol; 2018 May; 119(5):1608-1628. PubMed ID: 29357448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β band stability over time correlates with Parkinsonian rigidity and bradykinesia.
    Little S; Pogosyan A; Kuhn AA; Brown P
    Exp Neurol; 2012 Aug; 236(2):383-8. PubMed ID: 22572590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta reactivity, prospective facilitation of executive processing, and its dependence on dopaminergic therapy in Parkinson's disease.
    Oswal A; Litvak V; Sauleau P; Brown P
    J Neurosci; 2012 Jul; 32(29):9909-16. PubMed ID: 22815506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-range temporal correlations in the subthalamic nucleus of patients with Parkinson's disease.
    Hohlefeld FU; Huebl J; Huchzermeyer C; Schneider GH; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Eur J Neurosci; 2012 Sep; 36(6):2812-21. PubMed ID: 22985199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease.
    van Wijk BC; Beudel M; Jha A; Oswal A; Foltynie T; Hariz MI; Limousin P; Zrinzo L; Aziz TZ; Green AL; Brown P; Litvak V
    Clin Neurophysiol; 2016 Apr; 127(4):2010-9. PubMed ID: 26971483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease.
    Toledo JB; López-Azcárate J; Garcia-Garcia D; Guridi J; Valencia M; Artieda J; Obeso J; Alegre M; Rodriguez-Oroz M
    Neurobiol Dis; 2014 Apr; 64():60-5. PubMed ID: 24361601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Movement related dynamics of subthalmo-cortical alpha connectivity in Parkinson's disease.
    Oswal A; Brown P; Litvak V
    Neuroimage; 2013 Apr; 70():132-42. PubMed ID: 23277109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Meidahl AC; Moll CKE; van Wijk BCM; Gulberti A; Tinkhauser G; Westphal M; Engel AK; Hamel W; Brown P; Sharott A
    Neurobiol Dis; 2019 Jul; 127():101-113. PubMed ID: 30753889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interhemispheric functional interactions between the subthalamic nuclei of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Eur J Neurosci; 2014 Oct; 40(8):3273-83. PubMed ID: 25195608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa Effect on Basal Ganglia Motor Circuit in Parkinson's Disease.
    Gao LL; Zhang JR; Chan P; Wu T
    CNS Neurosci Ther; 2017 Jan; 23(1):76-86. PubMed ID: 27663605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.
    Holt AB; Kormann E; Gulberti A; Pötter-Nerger M; McNamara CG; Cagnan H; Baaske MK; Little S; Köppen JA; Buhmann C; Westphal M; Gerloff C; Engel AK; Brown P; Hamel W; Moll CKE; Sharott A
    J Neurosci; 2019 Feb; 39(6):1119-1134. PubMed ID: 30552179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional segregation of basal ganglia pathways in Parkinson's disease.
    Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
    Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.